“…Nonetheless, two issues arise in this case, it is not biologically feasible to constantly applied an immunotherapy treatment to a cancer patient and it is evident that the solution of the effector T cells goes to the value 256,596 cells/μL (a concentration close to that of the the maximum carrying capacity of the CML cancer cells) which could produce adverse events in the patient’s health [ 36 ]. Hence, in order to avoid the latter, numerous authors have proposed different treatment strategies to apply therapies such as chemotherapy, radiotherapy and immunotherapy by time intervals or in the form of periodic oscillations, one can see [ 14 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ]. Thus, our hypothesis is as follows: Daily applications for a finite period of time of the immunotherapy treatment will decrease the CML cancer cells concentration below a critical threshold under which it is possible to ensure the complete eradication of the disease.…”